Regis Healthcare Ltd (ASX: REG) Share Price and News
Price
$6.595
Movement
0.075 (+1.15%)
as at 29 Apr 10:46am (20 mins delayed)
52 Week Range
$3.73 - $6.95
1 Year Return
+64.88%
Regis Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$1.96 billion
P/E Ratio
134.73
Dividend Yield
2.18%
Shares Outstanding
301.25 million
Earnings per share
0.050
Dividend per share
0.16
Year To Date Return
13.85%
Earnings Yield
0.74%
Franking
59.9505562423
Share Price
$6.595
Day Change
0.075 (+1.15%)
52 Week Range
$3.73 - $6.95
Yesterday's Close
$6.52
Today's Open
$6.52
Days Range
$6.52 - $6.62
Volume
2,280,363
Avg. Volume (1 month)
630,804
Turnover
$14,927,129
as at 29 Apr 10:46am
Regis Healthcare Ltd (ASX: REG)
Latest News
Healthcare Shares
Macquarie's top 3 ASX stock picks in the healthcare sector
Dividend Investing
Looking for last-minute dividends? 25 ASX shares going ex-dividend next week
Share Gainers
Why EML Payments, Gentrack, Regis, and Resimac shares are racing higher
Healthcare Shares
3 ASX healthcare shares surging on big news
Healthcare Shares
3 small-cap ASX healthcare shares 'with strong prospects'
Healthcare Shares
A 'golden era' is coming for these ASX healthcare shares
Broker Notes
2 ASX shares to buy with strong long-term growth plans
52-Week Highs
6 ASX 300 shares that hit new 52-week highs today
Share Gainers
Why Develop Global, Ioneer, Regis Healthcare, and Zip shares are racing higher today
Healthcare Shares
Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition
Healthcare Shares
'Next decade is likely to be a golden era' for ASX shares in this sector
Share Gainers
This ASX All Ords share has sneakily climbed 128% over the past year
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 13 Mar 2025 | $0.0809 | 59.95% | Interim | 10 Apr 2025 |
| 10 Sep 2024 | $0.0664 | 50.00% | Final | 25 Sep 2024 |
| 14 Mar 2024 | $0.0628 | 50.00% | Interim | 11 Apr 2024 |
| 12 Sep 2023 | $0.0748 | 50.00% | Final | 27 Sep 2023 |
| 16 Mar 2023 | $0.0200 | 50.00% | Interim | 14 Apr 2023 |
| 15 Sep 2022 | $0.0232 | 50.00% | Final | 30 Sep 2022 |
| 10 Mar 2022 | $0.0352 | 50.00% | Interim | 08 Apr 2022 |
| 15 Sep 2021 | $0.0463 | 50.11% | Final | 30 Sep 2021 |
| 10 Mar 2021 | $0.0200 | 50.00% | Interim | 08 Apr 2021 |
| 11 Mar 2020 | $0.0402 | 50.00% | Interim | 30 Sep 2020 |
| 11 Sep 2019 | $0.0711 | 100.00% | Final | 26 Sep 2019 |
| 13 Mar 2019 | $0.0812 | 100.00% | Interim | 11 Apr 2019 |
| 11 Sep 2018 | $0.0865 | 100.00% | Final | 26 Sep 2018 |
| 13 Mar 2018 | $0.0928 | 100.00% | Interim | 11 Apr 2018 |
| 01 Sep 2017 | $0.0000 | 100.00% | Final | 18 Sep 2017 |
| 03 Mar 2017 | $0.1030 | 100.00% | Interim | 20 Mar 2017 |
| 02 Sep 2016 | $0.0594 | 100.00% | Final | 19 Sep 2016 |
| 03 Mar 2016 | $0.0940 | 100.00% | Interim | 21 Mar 2016 |
| 03 Mar 2004 | $0.0700 | 100.00% | Interim | 24 Mar 2004 |
REG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 11th Apr 2025 2025-04-11T16:28:03 | Ceasing to be a substantial holder | YesNo | 4:28pm | 3 | 130k |
| 12th Mar 2025 2025-03-12T17:14:30 | Change in substantial holding | YesNo | 5:14pm | 4 | 329k |
| 24th Feb 2025 2025-02-24T10:09:20 | FY25 Half-Year Results - Webinar Link | YesNo | 10:09am | 1 | 121k |
| 24th Feb 2025 2025-02-24T09:03:05 | Dividend/Distribution - REG | YesNo | 9:03am | 4 | 14k |
| 24th Feb 2025 2025-02-24T08:54:55 | REG Investor Presentation 1H FY25 | YesNo | 8:54am | 32 | 3M |
| 24th Feb 2025 2025-02-24T08:49:40 | REG Results Announcement 1H FY25 | YesNo | 8:49am | 5 | 224k |
| 24th Feb 2025 2025-02-24T08:44:41 | REG Appendix 4D and Half- Year Financial Report H1 FY25 | YesNo | 8:44am | 37 | 2M |
| 4th Feb 2025 2025-02-04T16:31:44 | Notification of 1H FY25 Results Date | YesNo | 4:31pm | 1 | 123k |
| 6th Jan 2025 2025-01-06T08:58:48 | Regis acquires home care business in VIC and South-East QLD | YesNo | 8:58am | 2 | 101k |
| 30th Dec 2024 2024-12-30T13:12:31 | Change of Director's Interest Notice | YesNo | 1:12pm | 3 | 233k |
About Regis Healthcare Ltd
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
REG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 28 Apr 2025 | $6.52 | $-0.23 | -3.41% | 2,958,526 | $6.83 | $6.84 | $6.48 |
| 24 Apr 2025 | $6.75 | $0.00 | 0.00% | 601,155 | $6.79 | $6.90 | $6.68 |
| 23 Apr 2025 | $6.75 | $0.14 | 2.12% | 383,137 | $6.47 | $6.78 | $6.47 |
| 22 Apr 2025 | $6.61 | $-0.08 | -1.20% | 363,049 | $6.50 | $6.67 | $6.50 |
| 17 Apr 2025 | $6.69 | $0.08 | 1.21% | 269,645 | $6.40 | $6.73 | $6.36 |
| 16 Apr 2025 | $6.61 | $-0.12 | -1.78% | 441,814 | $6.63 | $6.76 | $6.47 |
| 15 Apr 2025 | $6.73 | $0.06 | 0.90% | 338,425 | $6.70 | $6.78 | $6.65 |
| 14 Apr 2025 | $6.67 | $0.11 | 1.68% | 248,515 | $6.60 | $6.71 | $6.49 |
| 11 Apr 2025 | $6.56 | $-0.10 | -1.50% | 592,489 | $6.66 | $6.66 | $6.44 |
| 10 Apr 2025 | $6.66 | $0.29 | 4.55% | 527,582 | $6.80 | $6.82 | $6.66 |
| 09 Apr 2025 | $6.37 | $-0.13 | -2.00% | 827,919 | $6.50 | $6.73 | $6.35 |
| 08 Apr 2025 | $6.50 | $0.11 | 1.72% | 352,695 | $6.55 | $6.59 | $6.42 |
| 07 Apr 2025 | $6.39 | $-0.16 | -2.44% | 804,171 | $6.50 | $6.51 | $6.22 |
| 04 Apr 2025 | $6.55 | $-0.21 | -3.11% | 781,113 | $6.60 | $6.74 | $6.53 |
| 03 Apr 2025 | $6.76 | $-0.01 | -0.15% | 360,117 | $6.80 | $6.80 | $6.58 |
| 02 Apr 2025 | $6.77 | $0.10 | 1.50% | 324,475 | $6.79 | $6.81 | $6.71 |
| 01 Apr 2025 | $6.67 | $-0.09 | -1.33% | 605,117 | $6.77 | $6.77 | $6.61 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Dec 2024 | Linda Mellors | Issued | 166,495 | $1,030,604 |
Issue of securities. 942,873 - Rights
|
| 13 Nov 2024 | Jodie Leonard | Buy | 4,590 | $29,972 |
On-market trade.
|
| 13 Nov 2024 | Jodie Leonard | Buy | 3,100 | $20,243 |
On-market trade.
|
| 27 Sep 2024 | Linda Mellors | Issued | 18,163 | $112,973 |
Issue of securities. 776,378 Rights (unquoted)
|
| 27 Sep 2024 | Linda Mellors | Cancelled | 39,889 | $245,565 |
Cancellation of securities. Cessation of performance rights, 758,215 Rights
|
| 20 Sep 2024 | Linda Mellors | Issued | 71,035 | $421,237 |
Conversion of securities.
|
| 20 Sep 2024 | Linda Mellors | Exercise | 71,035 | $421,237 |
Conversion of securities. 798,104 Rights
|
| 30 May 2024 | Bryan Dorman | Sell | 17,500,000 | $68,250,000 |
Off-market trade.
|
| 28 May 2024 | Sally Freeman | Buy | 52,462 | $207,541 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Graham Hodges | Non-Executive DirectorNon-Executive Chairman | Aug 2017 |
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for 10 years before being seconded to the International Monetary Fund in Washington for several years. Graham built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. He is member of Risk and Compliance Committee.
|
| Professor Christine Constance Bennett | Non-Executive Director | Mar 2018 |
Professor Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. Christine is also Convenor of the Champions of Change Coalition Health Group for gender equality. From 2008 to 2010, Christine was Chair of the National Health and Hospitals Reform Commission to provide advice on a long-term reform plan for the future of the Australian health and aged care system. She is Chairman of the Clinical Governance and Care Committee, Member of the Risk and Compliance Committee and Property Committee.
|
| Mr Ian Gregory Roberts | Non-Executive Director | May 2007 |
Mr Roberts has over 35 years of experience in the real estate sector including more than 25 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South-East Queensland. Ian is currently a Non-Executive Director of several property and property services enterprises. He is Chairman of Property Committee.
|
| Ms Jodie Lee Leonard | Non-Executive Director | Nov 2023 |
Ms Leonard career spans over 30 years in ASX, NYSE and FTSE-listed companies and includes senior positions at General Electric, the Nine Network, British Airways and Telstra, having worked across Australia, the USA, UK, Asia and Europe. Jodie has experience in a range of industries including banking and financial services, superannuation, healthcare, technology, consumer goods, media and entertainment, and travel and tourism. She is member of Property Committee.
|
| Dr Linda Jane Mellors | Chief Executive OfficerManaging Director | Aug 2019 |
Dr Mellors has over 20 years of executive experience in health and aged care. Prior to joining Regis, Linda held a range of roles in hospital and health systems predominantly in Victoria, as well as a national aged care service. Linda was Chief Executive Health Services and Chief Operating Officer of the business at Mercy Health and the Co-Chair of the Victorian Metropolitan Hospital Chief Executive group. Linda is currently a Board Director of Mackillop Family Services and Director of the Australian Aged & Community Care Providers Association (AACPA).
|
| Ms Sally Margaret Freeman | Non-Executive Director | Jan 2022 |
Ms Freeman Chairs the Audit, Risk and Compliance Committee. She is Member of the Clinical Governance and Care Committee. She has experience in governance, risk and audit, with a career spanning over 30 years, ending in being the Partner in Charge of KPMG Australia's Risk Consulting practice and representing that practice on the international Board. She is Member of the Clinical Governance and Care Committee.
|
| Mr Malcolm Peter Ross | Company SecretaryGeneral Counsel | Nov 2021 |
-
|
| Rick Rostolis | Chief Financial Officer |
-
|
|
| Imtiaz Bhayat | Chief Information Officer |
-
|
|
| Malcolm Peter Ross | Company SecretaryGeneral Counsel |
-
|
|
| Melissa McDonald | Executive General Manager - Clinical and Care Practice |
-
|
|
| James Theofanis | Executive General Manager - Operations VIC/SA/TAS/WA |
-
|
|
| Georgia Willis | Executive General Manager - Property |
-
|
|
| Filomena Ciavarella | Executive General Manager - Strategy Quality and Improvement |
-
|
|
| Michelle Martella | Executive General Manager - Support Services |
-
|
|
| Gregg Funston | Executive General Manager Operations QLD/NSW/NT |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Galabay Pty Ltd Acn 010 849 153 | 81,910,479 | 27.21% |
| Ashburn Pty Ltd Acn 005 883 438 | 64,410,479 | 21.40% |
| Citicorp Nominees Pty Limited | 55,801,390 | 18.54% |
| HSBC Custody Nominees (Australia) Limited | 20,502,132 | 6.81% |
| J P Morgan Nominees Australia Pty Limited | 18,963,519 | 6.30% |
| Buttonwood Nominees Pty Ltd | 10,765,606 | 3.58% |
| National Nominees Limited | 5,030,324 | 1.67% |
| BNP Paribas Noms Pty Ltd | 3,729,341 | 1.24% |
| A10 Investments Pty Ltd | 3,210,000 | 1.07% |
| Ubs Nominees Pty Ltd | 2,432,989 | 0.81% |
| BKI Investment Company Limited | 1,807,428 | 0.60% |
| Mr Vincent Michael O'Sullivan | 1,606,000 | 0.53% |
| Neweconomy Com Au Nominees Pty Limited | 1,433,457 | 0.48% |
| BNP Paribas Noms Pty Ltd i | 1,300,830 | 0.43% |
| BNP Paribas Nominees Pty Ltd | 1,221,696 | 0.41% |
| Mr Ross James Johnston | 1,050,000 | 0.35% |
| BNP Paribas Nominees Pty Ltd ii | 1,030,726 | 0.34% |
| Bertalli Family Foundation Pty Ltd | 600,000 | 0.20% |
| Culloden Investments Pty Ltd | 600,000 | 0.20% |
| Netwealth Investments Limited | 479,337 | 0.16% |
| Citicorp Nominees Pty Limited ii | 383,040 | 0.13% |